Decision support tool for familial high cholesterol
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a computer tool that helps doctors identify and manage people with familial high cholesterol. It aims to improve care for those who may not yet have a diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You receive care at Brigham and Women's Hospital in endocrinology, heart medicine, or primary care clinics.
- You have a Dutch Lipid Clinic Network score of at least 3 points, which indicates a possible or definite family history of high cholesterol.
- You do not already have a diagnosis of familial high cholesterol in your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how doctors treat high cholesterol in patients at increased heart disease risk. By understanding current treatment approaches, researchers aim to improve how cholesterol is managed and reduce heart disease risk.
This study tests whether a special alert in your electronic health record can help doctors start the right cholesterol-lowering medication for people with peripheral artery disease (PAD) who are not already on one. The goal is to see if the alert helps get treatment started more often.
This trial tests a computer “decision support” tool for primary care clinics to help manage familial hypercholesterolemia, an inherited condition that can cause very high cholesterol. It may help clinics make more consistent decisions using patients’ health records.
This trial tests if a computer-based tool helps doctors follow guidelines for managing dyslipidemia (high cholesterol or fats in the blood). You may join if you have enough medical data available and agree to participate.
This trial focuses on people referred to a cholesterol (lipid) clinic to help identify inherited high cholesterol. It tests an “interpretive comment” approach to nudge detection—meaning it may help clinicians recognize who is most likely to have familial hypercholesterolemia.
This trial aims to identify kids and teens who may have inherited high cholesterol (especially LDL) and may be at higher risk for early heart artery disease. It may help families learn about their risk and ensure the right follow-up and treatment plan.
Hear when a new Familial Hypercholesterolaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.